France
Diabetes country report 2000 — 2050
Skip Map
Number of adults (20–79 years) with diabetes in France (FR)
| 2000 | 1.7 million |
| 2011 | 3.2 million |
| 2024 | 4.1 million |
| 2050 | 4.2 million |
France is one of the 60 countries and territories in the IDF Europe Region. France is on the top 10 countries in the world with the highest total diabetes-related health expenditure in 2024 in adults (20-79 years).
Data source(s) used for the diabetes estimates in adults:
- Bringer J, Fontaine P, Detournay B, Nachit-Ouinekh F, Brami G, Eschwege E. Diabetes Metab. 2009 Feb;35(1):25-31. PMID:19046913
- Bonaldi C, et al. Diabet Med. 2011 Feb 5. doi:10.1111/j.1464-5491.2011.0325.x. PMID:21294766.
- Lailler G, et al. Diabetes Research and Clinical Practice. 165.108252. 10.1016/j.diabres.2020.108252. PMID:32526264
2000
2011
2024
2050
Loading...
| Diabetes estimates (20-79 y) | ||||
|---|---|---|---|---|
| People with diabetes, in 1,000s | 1,656.8 | 3,237.6 | 4,107.0 | 4,243.9 |
| Age-standardised prevalence of diabetes, % | - | 5.4 | 6.5 | 7.8 |
| Proportion of people with undiagnosed diabetes, % | - | - | 24.1 | - |
| People with undiagnosed diabetes, in 1,000s | - | - | 989.0 | - |
| Impaired Fasting Glucose (IFG) | ||||
|---|---|---|---|---|
| People with IFG, in 1,000s | - | - | 3,003.7 | 2,980.5 |
| Age-standardised prevalence of IFG, % | - | - | 5.5 | 6.0 |
| Impaired Glucose Tolerance (IGT) | ||||
|---|---|---|---|---|
| People with IGT, in 1,000s | - | 4,167.4 | 5,320.6 | 5,304.0 |
| Age-standardised prevalence of IGT, % | - | 7.5 | 9.5 | 10.5 |
| Mortality attributable to diabetes (20-79 y) | ||||
|---|---|---|---|---|
| Deaths attributable to diabetes | - | 21,782.0 | 33,902.9 | - |
| Proportion of diabetes-related deaths in people 20-79 y, % | - | - | 14.2 | - |
| Hyperglycaemia in pregnancy (HIP) (20-49 y) | ||||
|---|---|---|---|---|
| Live births affected by HIP | - | - | 72,176.7 | - |
| Prevalence of gestational diabetes mellitus (GDM), % | - | - | 10.7 | - |
| Live births affected by other types of diabetes first detected in pregnancy | - | - | 1,532.1 | - |
| Live births affected by other types of diabetes detected prior to pregnancy | - | - | 4,830.4 | - |
| Diabetes-related health expenditure | ||||
|---|---|---|---|---|
| Total diabetes-related health expenditure, USD million | - | - | 22,500.4 | 21,150.2 |
| Total diabetes-related health expenditure, ID million | - | - | 25,188.8 | 23,677.2 |
| Diabetes-related health expenditure per person, USD | - | 5,632.0 | 5,478.5 | 4,983.7 |
| Diabetes-related health expenditure per person, ID | - | - | 6,133.1 | 5,579.2 |
| Type 1 diabetes estimates in children and adolescents | ||||
|---|---|---|---|---|
| People with type 1 diabetes (all age groups) | - | - | 174,694.0 | - |
| People with type 1 diabetes (0-19 y) | - | - | 26,423.7 | - |
| Demographics | ||||
|---|---|---|---|---|
| Total adult population (20-79 y), in 1,000s | 41,927.0 | 44,329.0 | 45,839.8 | 44,427.2 |
| Population of children and adolescents (0-19 y) | - | - | 15,113,763.0 | - |
Loading...
| Diabetes estimates (20-79 y) | |
|---|---|
| People with diabetes, in 1,000s | 1,656.8 |
| Age-standardised prevalence of diabetes, % | - |
| Proportion of people with undiagnosed diabetes, % | - |
| People with undiagnosed diabetes, in 1,000s | - |
| Impaired Fasting Glucose (IFG) | |
|---|---|
| People with IFG, in 1,000s | - |
| Age-standardised prevalence of IFG, % | - |
| Impaired Glucose Tolerance (IGT) | |
|---|---|
| People with IGT, in 1,000s | - |
| Age-standardised prevalence of IGT, % | - |
| Mortality attributable to diabetes (20-79 y) | |
|---|---|
| Deaths attributable to diabetes | - |
| Proportion of diabetes-related deaths in people 20-79 y, % | - |
| Hyperglycaemia in pregnancy (HIP) (20-49 y) | |
|---|---|
| Live births affected by HIP | - |
| Prevalence of gestational diabetes mellitus (GDM), % | - |
| Live births affected by other types of diabetes first detected in pregnancy | - |
| Live births affected by other types of diabetes detected prior to pregnancy | - |
| Diabetes-related health expenditure | |
|---|---|
| Total diabetes-related health expenditure, USD million | - |
| Total diabetes-related health expenditure, ID million | - |
| Diabetes-related health expenditure per person, USD | - |
| Diabetes-related health expenditure per person, ID | - |
| Type 1 diabetes estimates in children and adolescents | |
|---|---|
| People with type 1 diabetes (all age groups) | - |
| People with type 1 diabetes (0-19 y) | - |
| Demographics | |
|---|---|
| Total adult population (20-79 y), in 1,000s | 41,927.0 |
| Population of children and adolescents (0-19 y) | - |
